Denny offers extensive medical and product expertise, helping to strengthen ACM’s medical strategy and reinforce its industry leadership, Medtronic said in a news release. The company aims to deepen its relationships with the healthcare community, customers, partners and professional societies.
“We’re honored to welcome Dr. Denny to Medtronic,” said Kate Benedict, president of the Medtronic ACM business. “His relentless dedication to putting patient needs first aligns perfectly with our Mission, and I’m confident his expertise will play a key role in accelerating our innovation and growth.”
Denny joins the medtech giant from BD, having led medical affairs for multiple technologies and businesses there. Those units include Urology and Critical Care, Smart Connected Care and Vascular Device Access. Before his time at BD, Denny served as chief medical officer for the Medical Review Institute of America (MRIoA).
While taking on his new role at Medtronic, Denny intends to continue practicing medicine at the Physicians’ Care Clinic in Decatur, Georgia. His certifications include both nephrology and internal medicine.
“I am incredibly excited to join Medtronic and the ACM business at a time when personalized patient care is at the forefront of healthcare,” said Denny. “I am deeply aligned with the Medtronic commitment to patient safety and innovation — and to revolutionizing the future of healthcare to alleviate pain, restore health, and extend life.”
ACM unit continues to take shape at Medtronic
The makeup of Medtronic’s ACM unit continues to change, with several reconfigurations in recent years.
In February 2024, the company announced plans to exit what it labeled an increasingly unprofitable ventilator product line. That decision came more than a year after Medtronic said it would spin off its Patient Monitoring and Respiratory Interventions businesses, part of its Medical Surgical portfolio. Reports last year claimed that other medtech companies, including GE HealthCare and ICU Medical, as well as private equity firm Carlyle Group were among those considering a purchase of the businesses.
Ultimately, Medtronic leadership elected to end the ventilator business. As a result, it combined what remained of Patient Monitoring and Respiratory Interventions into one business unit — ACM.
As part of this change, Bob White, the EVP and president of the Medical Surgical portfolio for Medtronic, also departed. Not long after White’s departure, Ariel Mactavish, president of the Respiratory Interventions unit, also left.
In June, the company appointed Benedict as its new SVP and president for ACM as she joined the company’s Medical Surgical portfolio leadership team.
